Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Intravenous Immunoglobulin for the Treatment of Bronchopulmonary Dysplasia

NCT06925360 is registered in ClinicalTrials.gov with International Peace Maternity and Child Health Hospital as lead sponsor.

NCT NCT06925360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06925360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Intravenous Immunoglobulin for the Treatment of Bronchopulmonary Dysplasia
Lead sponsor
International Peace Maternity and Child Health Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
April 12, 2025
Completion date
December 31, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bronchopulmonary dysplasia